View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Elekta AB: 1 director

A director at Elekta AB sold 7,250 shares at 65.000SEK and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...

Simen Mortensen
  • Simen Mortensen

Sector optimism

In the past week, Citycon divested a retail asset in Norway, Logistea updated its financial targets following the merger with KMC Properties, Cibus carried out a rights issue as it is targeting M&A in the daily-goods property sector, and we saw sector optimism at DNB’s Nordic Real Estate & Construction Conference. The weighted-average implied EBITDA yields on the stocks we cover are 4.21% for 2024e and 4.65% for 2025e.

Simen Mortensen
  • Simen Mortensen

Bonds, market data and investments

This week, Castellum issued a EUR500m bond loan, and according to Bloomberg, Catena is contemplating launching 1–2 green bonds next week. Pandox acquired another UK asset, Logista and Public Property Invest look set to join the FTSE EPRA index, and finally, August data for Swedish and Norwegian house prices and commercial transaction volumes was published. The weighted-average implied EBITDA yields on the stocks we cover are 4.26% for 2024e and 4.70% for 2025e.

Patrik Ling
  • Patrik Ling

Elekta (Hold, TP: SEK76.00) - Stronger-than-expected Q1 report

Although a seasonally weak quarter, Q1 earnings were stronger than expected: sales beat consensus by c4% (3% above our estimate), adj. EBIT by 17% (6% above) and order intake by 9% (1% above). Overall guidance remained for a weaker H1 YOY and a stronger H2, and for the year, organic sales growth in the mid-single digits and an improved adj. EBIT margin YOY. We reiterate our HOLD and have raised our target price to SEK76 (74).

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Sten Gustafsson

Expect a roll-out and pick-up in H2

Americas drive a solid beat across the board. Q2 will remain soft, but new launches and improvements to come. Adj. EBIT up 1-2% for '24/'25e-'26/'27e.

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Sten Gustafsson
Simen Mortensen
  • Simen Mortensen

Hufvudstaden up to HOLD, layoffs in construction sector and rate cut

This week we upgraded Hufuvdstaden to HOLD following its Q2 results, JM is laying off 145 employees, and the Riksbank cut the policy rate by 25bp to 3.50%. While we retain our neutral stance on the Swedish real estate sector, we have turned slightly more positive since last month’s reduction in long-term market interest rates. The weighted-average implied EBITDA yields on the stocks we cover are 4.27% for 2024e and 4.71% for 2025e.

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Sten Gustafsson
Simen Mortensen
  • Simen Mortensen

More Q2 results and other news

The Q2 reporting season is again underway, following the summer break, with results from Olav Thon and Kojamo. In other news, Pandox announced it is considering a large UK investment, Norges Bank signalled the policy rate will not be cut near-term, and in Sweden, CPI has increased on an expected cut. The weighted-average implied EBITDA yields on the stocks we cover are 4.29% for 2024e and 4.74% for 2025e.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch